News

Filter

Current filters:

DermatologicalsUSA

1 to 9 of 26 results

Latest approval for Novartis’ Cosentyx, from US FDA

Latest approval for Novartis’ Cosentyx, from US FDA

22-01-2015

Adding to recent marketing clearances in Japan and the European Union, the US Food and Drug Administration…

BiotechnologyCosentyxDermatologicalsNovartisRegulationUSA

Leo Pharma files for US approval of first aerosol foam for psoriasis

06-01-2015

Independent Danish dermatology specialist Leo Pharma has submitted a New Drug Application to the US Food…

BetamethasonecalcipotrienecalcipotriolDermatologicalsLEO PharmaPharmaceuticalRegulationUSA

FDA approves Teva’s Granix and Galderma’s Soolantra

FDA approves Teva’s Granix and Galderma’s Soolantra

24-12-2014

The Food and Drug Administration has approved Israeli generics giant Teva Pharmaceutical Industries’…

DermatologicalsGaldermaGranixIvermectinPharmaceuticalRare diseasesRegulationSoolantraTeva Pharmaceutcal IndustriesUSA

US sales of Sanofi/Regeneron’s dupilumab for atopic dermatitis could exceed $1.3 billion by 2022, says analyst

04-12-2014

The first biologic to treat atopic dermatitis, French pharma major Sanofi (Euronext: SAN) and US biotech…

BiotechnologyDermatologicalsdupilumabMarkets & MarketingRegeneron PharmaceuticalsSanofiUSA

Regeneron and Sanofi granted breakthrough designation for dupilumab

Regeneron and Sanofi granted breakthrough designation for dupilumab

25-11-2014

US biotech Regeneron Pharmaceuticals and French pharma major Sanofi have said that the US Food and Drug…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

Sanofi and Regeneron’s dupilumab gets Breakthrough designation from FDA

20-11-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to French pharma major…

BiotechnologyDermatologicalsdupilumabRegeneronRegulationSanofiUSA

FDA panel unanimously backs Novartis’ secukinumab for moderate-to-severe plaque psoriasis

FDA panel unanimously backs Novartis’ secukinumab for moderate-to-severe plaque psoriasis

21-10-2014

The Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) to the US Food and Drug Administration…

DermatologicalsNovartisPharmaceuticalRegulationsecukinumabUSA

EADV: Celgene helps to raise awareness of psoriasis burden and presents new Otezla data

EADV: Celgene helps to raise awareness of psoriasis burden and presents new Otezla data

14-10-2014

US biotech company Celgene took a practical approach to raising awareness of psoriasis and psoriatic…

Celgene Corp.DermatologicalsEuropeHealthcareOtezlaPharmaceuticalResearchUSA

1 to 9 of 26 results

COMPANY SPOTLIGHT

Menarini

Back to top